Location History:
- 37077 Göttingen, DE (2009)
- Gottingen, DE (2012 - 2014)
- Göttingen, DE (2015)
- Goettingen, DE (2008 - 2016)
Company Filing History:
1 out of 10 
5 out of 832,812 Years Active: 2008-2016
Title: Hannelore Ehrenreich: Pioneering Innovations in Multiple Sclerosis Treatment
Introduction
Hannelore Ehrenreich is a notable inventor based in Goettingen, Germany, who has made significant contributions to the understanding and treatment of multiple sclerosis (MS). With a total of six patents to her name, her work focuses primarily on methods for the treatment and prophylaxis of MS, showcasing her dedication to improving the quality of life for those affected by this condition.
Latest Patents
Among her most recent innovations are two groundbreaking patents. The first patent details a method for the treatment and/or prophylaxis of multiple sclerosis, involving the use of erythropoietin (EPO) for the manufacture of a medicament aimed at the intermittent treatment and/or prophylaxis of MS. This invention not only offers new avenues for managing the disease but also highlights the therapeutic potential of EPO in this context.
The second patent introduces a method that seeks to improve the expanded disability status scale (EDSS) score in patients with multiple sclerosis. This innovative approach involves administering a substance that activates or stimulates the EPO receptor, leading to enhanced patient outcomes. The administration of this substance occurs in intervals, interspersed with application-free periods, promoting a refined and effective treatment regimen.
Career Highlights
Hannelore Ehrenreich has spent her professional journey focusing on the intersection of research and clinical application, contributing to the medical field through both her inventions and her collaborative endeavors. Her work has not only advanced scientific understanding but has also paved the way for potential new therapies for MS, positioning her as a leader in the field.
Collaborations
Throughout her career, Ehrenreich has collaborated with esteemed colleagues, notably Klaus-Armin Nave and Christoph Gleiter. These partnerships have enriched her research efforts and fostered an environment of innovation and academic exchange within the scientific community, driving forward the knowledge base surrounding multiple sclerosis.
Conclusion
Hannelore Ehrenreich stands out as a pioneering inventor whose innovative patents have the potential to reshape the landscape of multiple sclerosis treatment. With a keen focus on the application of erythropoietin and receptor activation, her work reflects a significant leap towards improved therapeutic strategies. As she continues to explore the complexities of MS, her contributions will undoubtedly leave a lasting impact on the lives of many.